文献速递脑血管病

内皮条件性敲低NMMHC IIA减轻缺血再灌注损伤中的血脑屏障破坏

Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.
PubMed 文献 · Stroke · 2021-02-16

该研究在体内外构建内皮条件性敲低NMMHC IIA(Myh9ECKD)模型,探讨其在缺血再灌注损伤中对血脑屏障破坏的作用及机制。结果显示NMMHC IIA在内皮细胞中表达上调,敲低可改善内皮屏障通透性及紧密连接完整性,并调控Hippo及PPARγ/NF-κB信号通路。NMMHC IIA可能成为缺血性卒中的潜在治疗靶点。

要点

  • 内皮条件性敲低NMMHC IIA可改善脑缺血再灌注后的内皮屏障高通透性
  • NMMHC IIA抑制剂blebbistatin具有与敲低相似的改善血脑屏障效果
  • NMMHC IIA通过Hippo及PPARγ/NF-κB信号通路参与血脑屏障损伤调控

核心结论

  • NMMHC IIA通过调控Hippo及PPARγ/NF-κB信号通路参与脑缺血再灌注后血脑屏障破坏,敲低NMMHC IIA可减轻内皮屏障损伤。

研究设计与样本

  • 在体内外构建内皮条件性敲低NMMHC IIA(Myh9ECKD)模型,并在大脑中动脉闭塞/再灌注损伤小鼠及氧糖剥夺/再氧合损伤的脑微血管内皮细胞中探究其作用。

主要发现

  • 脑缺血再灌注损伤后内皮细胞中NMMHC IIA表达上调。
  • Myh9ECKD小鼠在脑缺血再灌注刺激下内皮屏障高通透性改善、紧密连接完整性改善。
  • Blebbistatin(NMMHC II抑制剂)处理发挥相同效果。
  • 转录组学显示NMMHC IIA参与调控大脑中动脉闭塞/再灌注模型中多种血脑屏障相关基因组变化。
  • NMMHC IIA被证实显著调控与血脑屏障损伤密切相关的Hippo及PPARγ/NF-κB信号通路。

临床怎么用

  • NMMHC IIA可作为缺血性卒中血脑屏障保护干预的潜在靶点,但尚未进入临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In ischemic stroke, breakdown of the blood-brain barrier (BBB) aggravates brain damage. Endothelial detachment contributes to BBB disruption and neurovascular dysfunction, but its regulation in stroke has yet to be clarified. We investigated the function of NMMHC IIA (nonmuscle myosin heavy chain IIA) in the endothelium on BBB breakdown and its potential mechanisms. METHODS: Endothelial conditional knockdown NMMHC IIA (Myh9ECKD) was constructed in vivo and in vitro, and its role was explored in middle cerebral artery occlusion/reperfusion-injured mice and oxygen-glucose deprivation/reoxygenation-injured brain microvascular endothelial cells. The degree of brain injury was analyzed using staining (2,3,5-triphenyltetrazolium chloride, hematoxylin, and eosin) and electron microscopy. BBB breakdown was investigated with leakage of Evans Blue dye and expression of TJs (tight junctions) and MMP (matrix metallopeptidase)-2/9. Transcriptomics for enrichment analysis was adopted to explore the potential downstream signaling pathways of NMMHC IIA involved in middle cerebral artery occlusion/reperfusion-induced BBB dysfunction. RESULTS: NMMHC IIA expression was upregulated in endothelial cells after cerebral ischemia/reperfusion injury. Myh9ECKD mice exhibited improvement in endothelial barrier hyperpermeability and TJs integrity stimulated by cerebral ischemia/reperfusion. Blebbistatin (NMMHC II inhibitor) treatment exerted the same effect. Transcriptomics showed that NMMHC IIA was involved in regulating various BBB-related genomic changes in the middle cerebral artery occlusion/reperfusion model, and NMMHC IIA was confirmed to significantly modulate Hippo and peroxisome proliferator-activated receptor gamma/nuclear factor-kappa B signaling pathways, which are closely related to BBB damage. CONCLUSIONS: Our findings provide some new insights into how NMMHC IIA contributes to maintaining the integrity of the cerebral endothelial barrier. NMMHC IIA could be a potential therapeutic target for ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gong S, Cao G, Li F, et al. Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury. Stroke. 2021. PMID: 33588591. doi:10.1161/STROKEAHA.120.031410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。